# FDA recall D-0166-2020

> **AuroMedics Pharma LLC** · Class III · drug recall initiated 2019-09-23.

## Product

Ranitidine Tablets USP,150 mg,  8-count bottles,  Distributed by: Dolgencorp, LLC, 100 Mission Ridge, Goodlettsville, TN 37073 Made in India NDC 55910-092-79

## Reason for recall

CGMP DEVIATIONS: One lot of Ranitidine Tablets USP, 150 mg is being recalled because some bottles were empty.

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0166-2020
- **Recalling firm:** AuroMedics Pharma LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2019-09-23
- **Report date:** 2019-11-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Windsor, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0166-2020

## Citation

> AI Analytics. FDA recall D-0166-2020. Retrieved 2026-06-15 from https://api.ai-analytics.org/recall/D-0166-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*